FREQ Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 nov 2023 @ 21:00):

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function...

Stats
Dagens volum	309 164
Gjennomsnittsvolum	135 075
Markedsverdi	10.94M
EPS	$0 ( 2024-03-08 )
Neste inntjeningsdato	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.158
ATR14	$0.0510 (17.02%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-27	Meyers Rachel	Buy	12 551	Stock Option (Right to Buy)
2023-11-27	Meyers Rachel	Buy	0
2023-11-22	Lucchino David L.	Sell	110	Common Stock
2023-11-22	Lucchino David L.	Sell	230	Common Stock
2023-11-22	Lucchino David L.	Sell	614	Common Stock

INSIDER POWER
96.44
Last 81 transactions
Buy: 3 077 272 \| Sell: 64 406

Volum Korrelasjon

Lang: 0.24 (neutral)

Kort: -0.40 (neutral)

Signal:(51.699) Neutral

Frequency Therapeutics Korrelasjon

10 Mest positive korrelasjoner
AMGN	0.895
REVB	0.883
GLPG	0.882
STAF	0.873
GMII	0.873
ZYXI	0.872
SNES	0.871
IMPL	0.867
YQ	0.866
LBTYK	0.864

10 Mest negative korrelasjoner
SHSP	-0.952
MMAC	-0.944
BNFT	-0.922
XOG	-0.904
EXFO	-0.895
GTYH	-0.89
MNTX	-0.887
ANDA	-0.886
COUP	-0.884
FTNT	-0.868

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Frequency Therapeutics Korrelasjon - Valuta/Råvare

-0.43
( neutral )

0.21
( neutral )

0.00
( neutral )

-0.47
( neutral )

0.31
( neutral )

Frequency Therapeutics Økonomi

Annual	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-2.33

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-2.33

FY	2021
Omsetning:	$14 068.00
Bruttogevinst:	$14 068.00 (100.00 %)
EPS:	$-0.00246

FY	2020
Omsetning:	$36.98M
Bruttogevinst:	$36.98M (100.00 %)
EPS:	$-0.820

Financial Reports:

No articles found.

Frequency Therapeutics

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.

Sanntidsoppdatering for Frequency Therapeutics [FREQ]

Upcoming Earnings Alert